BONE MARROW CHARACTERISTICS IN PATIENTS WITH PRIMARY MYELOFIBROSIS AT THE NATIONAL INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION
Main Article Content
Abstract
Objectives: To study some characteristics of bone marrow in patients with primary myelofibrosis at the National Institute of Hematology and Blood Transfusion. Subjects and methods: We conducted a retrospective cross-sectional study on 43 patients diagnosed with primary myelofibrosis at the Department of General Blood Diseases, National Institute of Hematology and Blood Transfusion, from January 2017 to May 2022. Results: Most patients with primary myelofibrosis had poor marrow density, accounting for 65.1%. Bone marrow decreased erythrocyte production (69.8%), most of which had red blood cell line morphological disorders. 53.5% of patients had a decreased leukocyte lineage. Leukocyte morphology disorder accounted for 93%, mainly disorders in the intermediate stage of granulocytes. 100% of patients had fibroblast proliferation at different levels accompanied by morphological disorders of megakaryocyte (55.8% of megakaryocytes with large size, large shaggy nuclei with reduced abs; bare megakaryocytes nuclei accounted for 9.3%), megakaryocytes standing in groups accounted for 69.8%.
Article Details
Keywords
Primary myelofibrosis, bone marrow, morphology
References
2. Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood,2016;127(20):2391-2405.
3. Teffri A. Myelofibrosis with myeloid metaplasia. New England Jounrnal of Medicine, 2000;342:1255-65.
4. Dương Thị Thuỳ Linh. Đặc điểm mô bệnh học và mức độ xơ ở một số bệnh tăng sinh tuỷ mạn ác tính tại bệnh viện Bạch Mai. Luận văn chuyên khoa cấp II; 2021
5. Vũ Đức Bình. Nghiên cứu đặc điểm lâm sàng và xét nghiệm bệnh xơ tuỷ nguyên phát tại Viện Huyết học - Truyền máu TW giai đoạn 2015-2017, Tổng hội Y Học Việt Nam; BV1; Tập 466; Số đặc biệt; Tháng 5/2018 – 932-939
6. Nazha A, Estrov Z, Cortes J, Bueso-Ramos CE, Kantarjian H, Verstovsek S. Prognostic implications and clinical characteristics associated with bone marrow fibrosis in patients with myelofibrosis. Leuk Lymphoma. 2013; 54(11):2537-2539.
7. Olga Pozdnyakova, Kaida Wu, Abhay Patki. High concordance in grading reticulin fibrosis and cellularity in patients with myeloproliferative neoplasms. Modern pathology,2014;27,1447-1454.
8. Umberto Gianelli, et al. The European Consensus on grading of bone marrow fibrosis allows a better prognostication of patients with primary myelofibrosis. Mod Pathol, 2012;25(9):1193:202.